Compare INCR & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INCR | ZTEK |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.3M | 78.2M |
| IPO Year | N/A | N/A |
| Metric | INCR | ZTEK |
|---|---|---|
| Price | $0.97 | $1.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 190.8K | 82.4K |
| Earning Date | 02-15-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $72,158,312.00 | $657,134.00 |
| Revenue This Year | $69.54 | N/A |
| Revenue Next Year | $41.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $0.68 | $0.62 |
| 52 Week High | $1.78 | $1.84 |
| Indicator | INCR | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 35.54 | 66.10 |
| Support Level | $0.90 | $0.64 |
| Resistance Level | $1.08 | $1.09 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 55.49 | 71.11 |
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.